Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass-Reference-Cited by-同舟云学术

Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass

Published:2019-10 Issue:17 Volume:74 Page:2178-2189
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Pireaux Valérie,Tassignon Joël,Demoulin Stéphanie,Derochette Sandrine,Borenstein Nicolas,Ente Angélique,Fiette Laurence,Douxfils Jonathan,Lancellotti Patrizio,Guyaux Michel,Godfroid Edmond

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents;Crowther;Blood,2008

2. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Schulman;Chest,2008

3. Heparin-induced thrombocytopenia;Arepally;Blood,2017

4. The evaluations of frequency distribution heparin resistance during coronary artery bypass graft;Bagheri;Adv Biomed Res,2014

5. Predictors of heparin resistance before cardiovascular operations in adults;Kawatsu;Ann Thorac Surg,2018

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Développement clinique des thérapeutiques anti-facteur XII ciblant la thrombo-inflammation;La Revue de Médecine Interne;2024-08

2. Steps Toward Recapitulating Endothelium: A Perspective on the Next Generation of Hemocompatible Coatings;Macromolecular Bioscience;2024-07-29

3. Therapeutic Potential of FXI Inhibitors: Hype or Hope?;Drugs;2024-07-29

4. Anticoagulation: Past, Present, and Future Therapies;Anticoagulation - An Update;2024-07-03

5. The current landscape of factor XI inhibitors;Thrombosis Update;2024-06